Document is current

Any future updates will be listed below

Clinically early-stage CSPĪ± mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss

Crossref DOI link: https://doi.org/10.1186/s40478-015-0256-5

Published Online: 2015-11-26

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark